About TransSine Techologies

TransSINE Technologies aims at bringing SINEUP RNA molecules from research discovery to the creation of products that will contribute to improve biotechnology research, industrial-scale protein synthesis and RNA therapeutics.

TransSINE Technologies is a RIKEN Venture biotechnology company (www.riken.jp) co-founded by Piero Carninci and Stefano Gustincich in December 2011.

TransSINE Technologies headquarter is in Japan (RIKEN Genome Science Center, Yokohama).
As RIKEN Venture, TransSINE Technologies receives logistic support from one of the most eminent Japanese research institutions and it is located in one of the most important Genome centers worldwide.